Regenxbio, Solid report data with Duchenne gene therapies
Regenxbio and Solid Bio say their gene therapies for Duchenne muscular dystrophy show no sign so far of the liver issues seen with Sarepta's Elevidys.
NHS hospitals 'should resist Palantir software rollout'
Hospitals in England have been told they do not have to deploy a controversial Palantir data platform by a coalition led by healthcare charity Medact.
Immutep investors spooked by LAG-3 failure in lung cancer
Friday the 13th has turned into a horror story for Immutep, whose share price has collapsed after it abandoned a pivotal trial of its LAG-3 drug efti.
Poll finds Americans cutting back elsewhere to fund health
Many Americans are forced to make difficult trade-offs with living expenses and delay life events like retirement to afford health, says a new poll.
Iran hackers claim cyberattack at US medtech firm
Cyberattack by an Iranian group against Stryker points to a shift in strategy from extortive to destructive assaults, as geopolitical conflicts rise.
Sales & Marketing
Digital
Market Access
Oncology
Patients
R&D
Partner Content
The Evolution Summit Announces May 2026 Program for Clinical...
marcus evans announces The Evolution Summit, taking place May 7-8, 2026 at The Ritz-Carlton, Fort Lauderdale, Florida.
PHARMAP 2026: Where Pharma Meets Policy
The Pharmaceutical Manufacturing and Packaging Congress (PHARMAP 2026)
7th Dermatology Drug Development Summit Europe
The Summit is a premier three-day industry event designed for senior leaders, clinical scientists, regulatory experts and commercial strategists
The PM Society Launches Pharmony to Support More Effective P...
The Pharmaceutical Marketing Society (PM Society) today announces the launch of Pharmony
EVERSANA Names Monica Avram Executive Vice President and Chi...
As chief legal officer and a member of the Executive Leadership Team, Monica Avram leads EVERSANA's global Legal and Compliance function.